Janice Schwartz Gave Talk to European Geriatric Medicine Society

Dr. Janice Schwartz gave a talk at the European Geriatric Medicine Society (at 3:30 am CA time) on October 13 entitled:  "Do we have a roadmap for new drug evaluation in older Adults in the U.S.?".

Five common gene variants identify elevated genetic risk for coronary heart disease.

A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).

Are We Choosing Wisely? Older Adults' Cancer Screening Intentions and Recalled Discussions with Physicians About Stopping.

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy-PENELOPE-B.

Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.

Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs.

Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance.

The changing landscape of aortic valve replacement in the USA.

Social determinants of inflammatory markers linking depression and type 2 diabetes among women: A scoping review.

Topical antacid therapy for capsaicin-induced dermal pain: a poison center telephone-directed study.

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.

Respiratory equality: let's stop playing favorites with COVID-19 in the healthcare setting.

Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.